As the FDA enforces the requirement for electronic data submission using SEND, pharmaceutical and biotech companies must adapt to this data-driven paradigm. PointCross Life Sciences emerges as a trusted partner, offering cloud-hosted or on-premises non-clinical solutions that streamline the process of becoming SEND ready. Embracing PointCross solutions empowers organizations to comply with regulatory mandates efficiently, optimize data management, and stay ahead of the curve in an increasingly data-centric industry. Contact PointCross today and embark on a seamless journey towards compliance with the FDA’s SEND mandate.
Related Posts
Face-to-Face CDISC SEND at FDA
April 1 - 5, 2019 read more
Incorporating Histopathology data of organs and tissues for terminal subjects from a draft PDF report
Challenge: Necropsy data and histopathology results were available only as a PDF report after the study’s conclusion. The CRO-provided... read more
Importance of Data Consistency and Quality in SEND Submissions
With the recent release of the FDA’s binding guidance for electronic submission of nonclinical data, sponsor submissions will be... read more
Clinical Trials: Understanding the Basics, Types, and FAQs
Clinical trials are an essential part of the drug development process, allowing researchers to evaluate the safety and effectiveness... read more